Incidence and Impact of Routine Inflammatory Parameters on Outcome after Transcatheter Aortic Valve Replacement

Table 1

Baseline and postprocedural characteristics.

A	Overall (n = 81)	TF-TAVR (n = 40)	TA-TAVR (n = 41)	value
Age, years	82.1 ± 6.0	82.9 ± 4.9	81.2 ± 6.9	0.5
Male gender	40 (49.4)	19 (47.5)	21 (51.2)	0.8
Weight, kg	77.3 ± 16.5	74.6 ± 14.7	80.0 ± 17.9	0.1
Height, cm	167.8 ± 9.1	168.3 ± 9.1	167.2 ± 9.2	0.5
Logistic Euroscore I (%)	18.6 ± 12.7	15.3 ± 9.5	21.9 ± 14.6	0.02
Aortic valve area, cm2	0.8 ± 0.3	0.8 ± 0.3	0.8 ± 0.3	0.7
Mean transvalvular PG before TAVR, mmHg	38.5 ± 14.7	38.8 ± 12.7	38.0 ± 17.4	0.8
LVEF (%)	52.9 ± 13.7	56.8 ± 9.9	49.0 ± 15.8	0.05
CAD	41(50.6)	22 (55)	19 (46.3)	0.5
Prior MI	12 (14.8)	5 (12.5)	7 (17.1)	0.7
Prior PCI	28 (34.6)	15 (37.5)	13 (31.7)	0.6
Prior heart surgery	12 (14.8)	3 (7.5)	9 (22)	0.1
B
Mean transvalvular PG after TAVR, mmHg	9.3 ± 4.0	9.2 ± 4.2	9.5 ± 3.7	0.5
Vascular complications (major)	1 (1.2)	1 (2.5)	0 (0)	0.4
Vascular complications (minor)	2 (2.5)	2 (5)	0 (0)	0.2
Stroke (disabling)	0 (0)	0 (0)	0 (0)	—
Stroke (nondisabling)	2 (2.5)	2 (5)	0 (0)	0.2

Values are mean ± SD, n (%). CAD = coronary artery disease, LVEF = left ventricular ejection fraction, MI = myocardial infarction, PCI = percutaneous coronary intervention, PVD = peripheral vascular disease, PG = pressure.